-
Perspectives of Healthcare Providers and Patients with Relapsed/Refractory Multiple Myeloma on Treatment Priorities and Novel Therapies
16 Apr 2025 13:30 GMT
… autologous stem cell transplants and biologics, leading to challenging decisions for healthcare providers … factors such as demographics, patient medical history, socioeconomic status, and … SIRO Clinpharm UK Ltd; and editorial support, provided by Nucleus …
-
The Health Wrap: election scorecards, the “Trump effect”, climate health matters, nepotism in medicine – and some good news
16 Apr 2025 11:16 GMT
… unproven stem cell therapies, not being required to use other kinds of public health … causes of misinformation.
Nepotism in medicine
American schools, colleges and universities … work in primary care.
A opinion piece published in MedPage Today …
-
DSMB recommends continuation of BioCardia’s trial of cell therapy for heart failure
16 Apr 2025 09:50 GMT
… s low-dose 20 million cell cohort.
This data did … safety of mesenchymal stromal/stem cells (MSCs) in treating heart … cell therapy in partnership with Emory University School of Medicine.
Editorial … involved in the creation of editorial content.
Sign up for …
-
UAEM hosts 2nd annual conference to promote advancing health equity
14 Apr 2025 06:48 GMT
… “Future Frontiers in Healthcare: Advancing Medicine Accessibility,” aimed to … legal process for public comment, and they still … a fourth-year molecular, cell and developmental biology student … and worker health. Fundamental public health issues stem from the …
-
Maric’s FOIA-obtained emails discuss admin’s handling of Israel-Palestine conflict
16 Apr 2025 11:42 GMT
… way to contact Roklen.
Comment from University
University Spokesperson … seek guidance and expert opinion from the general counsel, … to support stem cell research at the UConn Health center in … conflict history by have atoxic opinion,” Kaminer wrote on Oct …
-
Multiple Myeloma Is Treatable, Not Curable. Is That Set to Change?
15 Apr 2025 17:52 GMT
… as cancerous plasma cells overtake healthy blood cells. A common … was consistent with the opinion of a growing number … ’re considered for a stem cell transplant after the drug regimen … dormant stage that often requires medication to maintain that dormancy,” …
-
A Cost-Effectiveness Analysis of Mosunetuzumab vs Tisagenlecleucel for Treatment of Third- or Higher-Line (3L+) Relapsed or Refractory (R/R) Follicular Lymphoma (FL) in Italy
15 Apr 2025 14:11 GMT
… disease, and prior autologous stem cell transplant (ASCT). A series … Italiana di Oncologia Medica ASCT, Autologous stem cell transplant; ATMP, Advanced … of EQ-5D health states. Value Health. 2013;16(5 … chmp-post-authorisation-summary-opinion-kymriah-ii-44_en. …
-
Emory begins enrolment for BioCardia’s trial of ischemic heart failure therapy
14 Apr 2025 17:02 GMT
… “stable” guideline-directed medical therapy.
Emory University … delivery system.
Maryland Stem Cell Research Fund provided support … US Centers for Medicare and Medicaid Services reimbursed it … completion in 2027.”
Editorial content is independently produced …
-
UPSC Essentials | Mains answer practice — GS 3 : Questions on use of technology in law enforcement and Genome India Project (Week 98)
15 Apr 2025 08:32 GMT
… with important implications for health and medicine, as well as … the country. (2016)
Stem cell therapy is gaining popularity in … burns. Describe briefly what stem cell therapy is and what advantages … to the internal security. Comment on the measures being …
-
More patients to be offered the choice to receive hospital care at home
12 Apr 2025 21:37 GMT
… plans that consist of medication, antibiotics or fluids … the National University Health System (NUHS) health cluster has expanded … recovering from hematopoietic stem cell transplants and total knee … according to MOH data.
Editorial consultant Sheralyn Tay, 43 …
About
© 1995-2025